期刊文献+

亚急性皮肤型红斑狼疮23例临床分析 被引量:2

Character of subacute cutaneous lupus erythematosis
下载PDF
导出
摘要 目的探讨亚急性皮肤型红斑狼疮的临床和病理表现,治疗经验及预后特点。方法回顾分析北京协和医院皮肤科2012年1月-2014年12月收治的23例亚急性皮肤型红斑狼疮患者的临床和组织病理特点以及治疗预后情况。结果皮损好发于面部,躯干;皮损主要表现为红斑,鳞屑性皮疹;典型的病理表现为表皮萎缩,基底层液化变性,真皮血管和附属器周围淋巴细胞为主的浸润;实验室检查以抗SSA抗体和ANA阳性为主要表现;治疗以羟氯喹,单用或合用激素治疗;大多数患者对治疗反应较好,部分患者出现反复。结论亚急性皮肤型红斑狼疮诊断主要依据典型的临床表现和实验室检查;羟氯喹和糖皮质激素是治疗亚急性皮肤型红斑狼疮的主要药物。 Objective To explore the clinical and histopathological manifestations, the therapy and prognosis of subacute cutaneous lupus erythematosis(SCLE). Methods The clinical data and histopathological features of 23 patients with SCLE diagnosed at Peking Union Medical College Hospital from January 2012 to December 2014 were retrospectively reviewed. Results The lesions of SCLE tended to occur on face and trunk. The lesions appeared erythema and scale. Histopathological features were atrophy of epidermis, hydropicdegeneration of the basal layer, a primarily lymphocytic perivascular and perifollicular inflammation infiltration occurs in dermis. Laboratory examination revealed positive ANA and antibodies to SSA antigen. Most patients responded well to treatment, while a few experienced recurrence when the treatment tapped or discontinued. Conclusion The diagnosis of SCLE is mainly based on clinical findings and laboratory examination. Hydroxychloroquine and middle-dose glucocorticoids are effective for the treatment of SCLE.
作者 朱铁山 方凯
出处 《中国医药导报》 CAS 2016年第11期125-128,共4页 China Medical Herald
关键词 亚急性皮肤型红斑狼疮 硫酸羟氯喹 糖皮质激素 抗核抗体 抗SSA抗体 Subacute cutaneous lupus erythematosis Hydroxychloroquine Glucocorticoids Antinuclear antibodies Antibodies to SSA antigen
  • 相关文献

参考文献23

  • 1Filho JP,Peixotol RL,Gomes Martins LV,et al. Lupus ery- thematosus: considerations about clinical,cutaneous and therapeutic aspects [J]. An Bras Dermatol,2014,89(1) : 118- 125.
  • 2Biazar C, Sigges J, Nikolaos P,et al. Cutaneous lupus ery- thematosus:first multicenter database analysis of 1002 pa- tients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) [J]. Autoimmunity Rev,2013,12 (3) : 444-454.
  • 3Tebbe B,Orphanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus [J]. Lupus, 1997,6(2) :96-104.
  • 4Gilliam JN,Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus [J]. J Am Acad Dermatol, 1981,4(4) :471-475.
  • 5Sontheimer R D,Thomas JQ. Subacute cubaeute lupusery thematosus:a cutaneous marker for a distinct lupusery themato sus subset [J]. J Arch Dermatol, 1979,115(5): 1409-1415.
  • 6Walling HW,Sontheimer RD. Cutaneous lupus erythemato- sus: issues in diagnosis and treatment [J]. Am J Clin Der- matol, 2009,10(6) : 365-381.
  • 7Callen JP,Klein J. Subacute cutaneous lupus erythemato- sus : clinical, serologic, immunogenetic and therapeutic con- siderations in seventy-two patients [J]. Arthritis Rheum., 1988,31 (8) : 1007-1013.
  • 8Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological,immunological, and genetic findings [J]. Au- toimmun Rev, 2005,4 (5) : 253-263.
  • 9Tebbe B,Mansmann U,Wollina U,et aL Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients [J]. Acta Derm Venere- ol, 1997,77 (4) : 305-308.
  • 10Sontheimer RD, Maddison PJ, Reichlin M, et al .Serologic and HLA associations in subacute cutaneous lupus ery- thematosus, a clinical subset of lupus erythematosus [J]. Ann Intern Med, 1982,97(5) :664-71.

二级参考文献10

  • 1周辉,张安平,陈敏珠,徐叔云,汪国良.白芍总甙对应激大鼠下丘脑一垂体一肾上腺轴和免疫功能的调节[J].中国药理学通报,1994,10(6):429-432. 被引量:27
  • 2Sontheimer R R,Thomas JQ. Subacute cubacute lupus erythematosus:a cutaneaus marker for a distinct lupus erythematosus subset. Arch Dermatol, 1979, 115 : 1409-1415.
  • 3Marzano AV. Nitrendipine-induced subacute cutaneous lupus erythematous. Eur J Dermato1,2003,13 : 213-216.
  • 4Ewa chlebus,Hanna Wolska. Subacute cutameovs lupus erythematosus, versus systemiac lupus eryematosus ;Diagnostic criteria and therapeutic implications. J Am Acad Dermatol, 1998,38: 407-412.
  • 5Weinstein cl, Littlejohn Go, Thomson NH, et al. severe visceral disease in sehacule cutaneows lupus erythmatosus. Arch Dermatol, 1987,123 : 638-640.
  • 6Diya F,Mutasim, Brian B, et al. A Practical guide for serologic evaluation of autoimmune connective tissues disease. J Am Acad Dermatol,2000,42 : 159-174.
  • 7Jewell ML,McCaulitt DP. Patient with cataneous lupus erythematosus who smoke are ! ess responsive to antimalarial treatment. J Am Acad Dermatol,2000,42:983-987.
  • 8肖堃.白芍总苷在自身免疫性疾病中的应用[J].中华临床免疫和变态反应杂志,2008,2(1):55-60. 被引量:32
  • 9彭友华,李建军.白芍总苷在皮肤科的应用及研究进展[J].皮肤性病诊疗学杂志,2010,17(3):250-252. 被引量:29
  • 10张宇虹,郭在培,焦晓燕,李萌萌,陈涛.白芍总苷作用机理及其在皮肤科的应用[J].中国麻风皮肤病杂志,2012,28(2):109-111. 被引量:13

共引文献2

同被引文献21

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部